Sesame oil improves biomarkers of glycemic control in women with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, controlled clinical trial

Sesame oil improves biomarkers of glycemic control in women with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, controlled clinical trial

Abstract Aim This study aimed to investigate whether sesame oil (SO) consumption could improve biomarkers of glycemic control, inflammation, and oxidative stress in women with metabolic dysfunction-associated steatotic liver disease (MASLD). Methods This randomized, double-blind, controlled trial in...

Full description

Saved in:
Bibliographic Details
Main Authors: Masoumeh Atefi, Hamid Vahedi, Mina Darand, Mohammad Hassan Entezari
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Nutrition
Subjects:
Glycemic control
Inflammation
Oxidative stress
Metabolic dysfunction-associated steatotic liver disease
Sesame oil
Online Access:https://doi.org/10.1186/s40795-025-01123-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40795-025-01123-0

Similar Items